Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail

NCT01180647 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Opiate Dependence

Interventions

DRUG: Extended-Release Naltrexone
BEHAVIORAL: Motivational Enhancement Counseling

Sponsor

NYU Langone Health

Collaborators

[object Object]
[object Object]